rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Immix Biopharma, Inc.

IMMX · Nasdaq

Health CareBiotechnologyNot moving yet

IMMX stood above a rising 150-day average in 48 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 21.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 3
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$10K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
105 (+33)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 48 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$101KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months0
Buyers · sellers2 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders105+33 on the quarter
New · exited46 · 13
Reported value$562.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Jupiter Topco LLCnew · filed 14 Aug 20269,783,192$100.8M+9,783,192
Saturn V Capital Management LPadded · filed 14 Aug 20264,658,429$48.0M+964,844+26.1%
EVENTIDE ASSET MANAGEMENT, LLCadded · filed 14 Aug 20263,891,019$40.1M+1,342,000+52.6%
STATE STREET CORPadded · filed 7 Aug 20262,996,935$30.9M+2,805,025+1461.6%
BlackRock, Inc.added · filed 7 Aug 20262,989,972$30.8M+2,521,595+538.4%
Deep Track Capital, LPnew · filed 14 Aug 20262,775,000$28.6M+2,775,000
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,507,122$25.8M+719,128+40.2%
Opaleye Management Inc.new · filed 14 Aug 20262,345,000$24.2M+2,345,000
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 20262,066,426$21.3M+316,226+18.1%
UBS Group AGadded · filed 13 Aug 20261,941,817$20.0M+1,864,985+2427.4%
31 Mar 2023 – 30 Jun 2026
1458102Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Carey Ng Company insiderDirector · last 22 May 20263 · 0
Gabriel S. Morris Company insiderCFO, President · last 22 May 20268 · 0
Helen C. Adams Company insiderDirector · last 22 May 20261 · 0
Ilya M. Rachman Company insiderCEO and Chairman · last 22 May 20268 · 0
Jane Buchan Company insiderDirector · last 22 May 20261 · 0
Jason Hsu Company insiderDirector · last 22 May 202614 · 0
Magda Marquet Company insiderDirector · last 22 May 20263 · 0
Nancy T. Chang Company insiderDirector · last 22 May 20260 · 0
Yekaterina Chudnovsky Company insiderDirector · last 22 May 20260 · 0
Sean Senn Company insiderOther · last 14 Jul 20220 · 2
Vladimir P. Torchilin Company insiderScientific Co-Founder · last 20 Dec 20212 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-31.6%
Share count trendFY 2025 · to 20 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$93.9M
Free cash flowFY 2025 · to 31 Dec 2025−$24.7M

Analyst forecasts

No analyst forecasts yet.